GG 575 GG 575
Pill imprint GG 575 GG 575 has been identified as Fluoxetine hydrochloride 10 mg.
Fluoxetine is used in the treatment of depression; anxiety and stress; panic disorder; obsessive compulsive disorder; schizoaffective disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Risk cannot be ruled out during pregnancy.
Fluoxetine 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Fluoxetine hydrochloride Images
- Imprint:
-
GG 575
GG 575 - Strength:
- 10 mg
- Color:
- White
- Size:
- 16.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- corn starch
D&C Yellow No. 10
FD&C Blue No. 1
gelatin
magnesium stearate
propylene glycol
silicon dioxide
sodium lauryl sulfate
titanium dioxide
- Drug Class:
- Selective serotonin reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-2823
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5319 | A S Medication Solutions LLC (repackager) |
| 68115-0143 | Dispensexpress Inc (repackager) |
Note: Inactive ingredients may vary.
More Fluoxetine Hydrochloride resources
- Fluoxetine
- Fluoxetine (Wolters Kluwer)
- Fluoxetine Delayed-Release Capsules (Wolters Kluwer)
- Fluoxetine Solution (Wolters Kluwer)
- fluoxetine (Cerner Multum)
- Alti-Fluoxetine Hydrochloride (Micromedex) - Includes Dosage Information
- Phl-Fluoxetine (Micromedex) - Includes Dosage Information
- fluoxetine (Micromedex) - Includes Dosage Information
- Fluoxetine Hydrochloride (AHFS DI)
- Fluoxetine (FDA)
- Fluoxetine Capsules (FDA)
- Fluoxetine Delayed Release Capsules (FDA)
- Fluoxetine Oral Solution (FDA)
- Sarafem Tablets (FDA)
- Fluoxetine Hydrochloride (Wolters Kluwer)


